Since 2009, we have been helping doctors and patients find the genetic causes of rare diseases. We help oncologists and cancer patients find the best therapy option. We continue to drive science forward with our own insights. We provide scientists and pharmaceutical companies with sequencing services for clinical trials and their research. Next-generation sequencing is our core technology which we make available in a high-throughput format. To ensure our high-quality standards, we are accredited according to CAP/CLIA, DIN EN ISO 15189, DIN EN ISO/IEC 17025, and our services are IVDR compliant (IVDR 2017/746).